Next Article in Journal
Association of the DNA Methylation of Obesity-Related Genes with the Dietary Nutrient Intake in Children
Next Article in Special Issue
Methylliberine Ingestion Improves Various Indices of Affect but Not Cognitive Function in Healthy Men and Women
Previous Article in Journal
CEBP-β and PLK1 as Potential Mediators of the Breast Cancer/Obesity Crosstalk: In Vitro and In Silico Analyses
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Foundational Nutrition: Implications for Human Health

1
Research, Nutrition, and Innovation, Athletic Greens International, Carson City, NV 89701, USA
2
Department of Kinesiology, Lipscomb University, Nashville, TN 37204, USA
3
Department of Geriatrics, Center for Translational Research in Aging & Longevity, Donald W. Reynolds Institute on Aging, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA
4
Exercise Science and Exercise Physiology, Kent State University, Kent, OH 44240, USA
5
Department of Nutrition, Food Studies, and Public Health, New York University-Steinhardt, New York, NY 10003, USA
*
Author to whom correspondence should be addressed.
Nutrients 2023, 15(13), 2837; https://doi.org/10.3390/nu15132837
Submission received: 5 May 2023 / Revised: 14 June 2023 / Accepted: 20 June 2023 / Published: 22 June 2023
(This article belongs to the Special Issue Foundational Nutrition for Human Health)

Abstract

:
Human nutrition, and what can be considered “ideal” nutrition, is a complex, multi-faceted topic which many researchers and practitioners deliberate. While some attest that basic human nutrition is relatively understood, it is undeniable that a global nutritional problem persists. Many countries struggle with malnutrition or caloric deficits, while others encounter difficulties with caloric overconsumption and micronutrient deficiencies. A multitude of factors contribute to this global problem. Limitations to the current scope of the recommended daily allowances (RDAs) and dietary reference intakes (DRIs), changes in soil quality, and reductions in nutrient density are just a few of these factors. In this article, we propose a new, working approach towards human nutrition designated “Foundational Nutrition”. This nutritional lens combines a whole food approach in conjunction with micronutrients and other nutrients critical for optimal human health with special consideration given to the human gut microbiome and overall gut health. Together, this a synergistic approach which addresses vital components in nutrition that enhances the bioavailability of nutrients and to potentiate a bioactive effect.

1. Introduction: The Nutritional Health Problem

Poor nutrition is a pervasive problem worldwide, impacting people of all backgrounds and ages. According to the World Health Organization (WHO), nearly one in three people globally suffers from some form of malnutrition, whether it is undernutrition, micronutrient deficiencies, or overweight and obesity [1]. Furthermore, these nutritional inadequacies have a profound effect on human health and vitality beyond simple nutrient deficiency diseases. As early as 1981, it was estimated that approximately 30–35% of cancer deaths in the USA were linked to diet in an article written stemming from a commission from the United States (US) congress [2]. Over the past 40 years, this problem persists as one in five deaths worldwide, primarily from cardiovascular disease and cancer, can be attributed to a suboptimal diet [3]. While the link between nutritional habits and physical health has been widely acknowledged, striking evidence suggests that our dietary choices have a profound effect on our mental well-being [4,5]. Large observational studies have detected associations between dietary habits, mental health, and well-being while numerous nutrition and supplementation interventions have yielded beneficial effects on indices of depression, anxiety, and quality of life [6,7,8,9,10,11].
Given the severity of this nutritional health crisis, a multi-faceted approach is required, including policy changes to improve food environments and sustainable agricultural practices, increased access to healthy foods, and nutrition education to promote healthy dietary habits. This review will explore the scientific underpinnings of Foundational Nutrition and propose it as a new model by which researchers and practitioners approach and implement nutritional interventions. Therefore, the purpose of this review is three-fold: (1) propose a new working definition of “Foundational Nutrition”, a term we will propose as a means for individuals to achieve their daily essential nutritional needs while setting the stage for human health and performance (e.g., cognitive, digestive, musculoskeletal, cardiovascular, etc.); (2) outline the specific areas in which the conventional approach to nutrition may need reconsideration and can be addressed by a new paradigm; (3) explore nutritional concepts and selected nutrients which may be essential for humans to achieve optimal nutritional health and improve their healthspan. Undeniably, issues related to socioeconomic status (e.g., food insecurities, restricted access to healthy foods, limited monetary funds) and regional climate (e.g., declining agricultural productivity, food availability and seasonality, alterations in nutrient quality of crops, global climate change) largely contribute to the potential inability to meet the nutritional needs of an individual which are covered in-depth elsewhere [12,13,14,15,16]. This discussion is not intended to be all-encompassing; instead, it serves as a starting point for scientific discourse and further exploration of nutrition to empower human vitality to thrive instead of simply providing the rudimentary needs for survival.

2. Foundational Nutrition Definition

The human body is a complex biological system with countless biochemical and physiologic reactions occurring every second. For a system so complex, the traditional approach to nutritional science has been to identify and manipulate these processes by isolating the system of interest, providing a targeted intervention, and subsequently evaluating the outcome—essentially this is the reductionistic scientific method we can attribute numerous medical and health advancements we have today [17]. However, due to the ever-increasing health crisis which does not appear to be improving, the nutritional sciences need to re-evaluate the way nutrients and nutrient requirements are assessed within our intricate biological systems. One can argue that we are attempting to fit the nutritional sciences into the reductionistic scientific model, rather than attempting to assess a new method to identify how a complex system can be matched by a very comprehensive nutritional approach [17,18].
Therefore, we present Foundational Nutrition as the lens by which we begin to address this complex system with a comprehensive, simplistic, yet synergistic model (Figure 1). This three-pronged Foundational Nutrition approach extends beyond macronutrients, requiring consideration of the following:

2.1. Leveraging Nutrient Synergy and Bioavailability

Nature produces foods composed of numerous combinations of macronutrients, micronutrients, phytonutrients, prebiotics, probiotics, and other bioactive compounds. These nutrients do not exist in isolation, but in a matrix of constituents with an array of enzymatic and metabolic targets. Human beings are complex organisms and the reductionistic and mechanistic method by which we are currently assessing nutrients attempts to isolate these systems as separate units and address them independently—separating the part from the whole. Therefore, taking a complex plant extract or food with multiple active constituents and isolating them down to one mechanistic target fails to capture the multi-targeting effects of these nutrients. Instead, the approach to scientific research through the lens of Foundational Nutrition must consider the synergistic effect of multiple biophysiological reactions occurring from these nutrients in a physiological context [18]. When combined, these nutrients have additive and amplified effects that may not necessarily be attributed to one particular constituent or molecular target, but instead is an effect resulting from a concerted effort of multiple different constituents and their affinity for multiple different physiologic targets. For example, the combination of vitamin C and E has been shown to preferentially protect cells from oxidative damage to a greater extent than each nutrient alone [19]. Furthermore, zinc status has been shown to influence vitamin A transport, metabolism, and utilization in the body [20]. We see this effect in the most simplistic form with the inverse relationship between fruit and vegetable intake with chronic disease, and now we must consider the countless other nutrients and their collective benefits through this new lens [21]. The concept of nutritional synergy extends even beyond the interaction of the nutrients themselves. The phenomenon of “nutrient microbial synergy” refers to the mutually beneficial relationship between nutrients and microorganisms in various ecosystems, including the human body [22]. It describes the synergistic interactions where nutrients provided by the diet support the growth and activity of beneficial microorganisms, while these microorganisms, in turn, contribute to nutrient cycling, availability, and overall ecosystem health [23]. Given the prevalence of nutrient deficiencies we will discuss in this review, an emphasis on consuming bioavailable forms of micronutrients may assist in meeting our nutritional needs [24]. One example is that magnesium consumed in the form of leafy greens has a higher bioavailability than those obtained in grain products [25]. Concerning supplementation, magnesium in certain forms (e.g., magnesium glycinate, citrate, chelated) have greater bioavailability in the human body in comparison to other forms of magnesium (e.g., magnesium oxide) [26,27]. We propose that by leveraging synergy and bioavailability concepts, individuals are more favorably positioned to meet their nutritional needs.

2.2. Nutrient Quality, Quantity, and Essential Nutrients

Foundational Nutrition incorporates highly bioavailable nutrients that not only includes the basic 26-essential vitamins and minerals, but also argues for a more inclusive approach which incorporates other conditionally essential nutrients (e.g., phytonutrients, omega-3 fatty acids, CoQ10, creatine, etc.), that most seldom find adequately in their diet [28]. Furthermore, we argue for the shift from nutrient quantity recommendations aimed at preventing deficiencies to recommended quantities which promote an improved healthspan and lifespan based on a body of recent, robust scientific research. This requires a comprehensive review of the literature with an emphasis on reassessing nutrient requirements, bioavailability, and quality that has yet to be appropriately considered as a variable in the nutritional health sciences.

2.3. An Emphasis on Supporting Nutrient Absorption through Gut Health

The gut extends beyond just the anatomical structures, but incorporates an ecosystem that when compromised has a profound impact on the function of many other systems. The gastrointestinal system is our body’s primary medium by which we absorb and assimilate various nutrients that we are incapable of synthesizing endogenously. Generally, the microbiome is largely responsible for the breakdown of nutrients to aid in the absorption process (carbohydrates, proteins, bile acids, etc.) and some nutrients require the microbiome or intrinsic factors in the gut to be readily absorbed (e.g., vitamin k, polyphenols, vitamin b12) [29,30,31]. Additionally, microbial dysbiosis decreases the capacity of the small intestine to utilize and absorb nutrients [32]. Commensal bacteria in the gut appear to regulate the expression of nutrient solute carrier transporters demonstrating a potential relationship between gut microbiota composition and mechanistic nutrient absorption [33]. Moreover, gut dysbiosis has been linked to many gastrointestinal disorders (e.g., irritable bowel syndrome, celiac disease, inflammatory bowel disease) as well as systemic conditions (e.g., respiratory issues, cardiovascular disease, metabolic disease, obesity). For example, some reports indicates that 40% of the world population suffers from some form of functional gastrointestinal (GI) disorders such as irritable bowel syndrome (IBS), and it is estimated that 80% of individuals with IBS suffer from small intestine bacterial overgrowth (SIBO) [34,35]. Patients with SIBO experience malabsorption of fat and fat-soluble vitamin deficiencies (D, E, A, and K) which can lead to other health concerns [36]. In addition, approximately 68% of patients with diarrheal IBS had significant bile acid malabsorption [37,38]. Furthermore, probiotic supplementation has been shown to improve nutrient malabsorption in those with gut dysbiosis [32].
Thus, it is reasonable to suggest that in order for humans to improve both lifespan and healthspan, we must address gut health as a priority given the various functions it serves for each organ system and the body as a whole. Therefore, gut health and function is emerging as a key limiting factor in human healthspan and lifespan. To promote health and vitality across all populations, gut health through nutrition should be the center of our focus as we look to the future of nutrition science.
Together, these three pillars drive Foundational Nutrition and provide a guideline and new model for scientists, clinicians, and the scientific community as a whole to consider as we approach this century where preventive nutritional approaches are essential in the promotion of health and the delay of chronic illness.

3. Challenges to an Exclusively Macronutrient-Focused Approach to Nutrition

The World Health Organization (WHO) estimates that 31% percent of the world’s population over the age of 18 are overweight with 13% being obese [39]. In the US, a staggering 66% of adults are overweight and 33% are obese, with those in the “very obese” category rapidly increasing [40]. Not only is the world population overconsuming calories, but we are compounding the negative health effects of excess calories by consuming diets low in micronutrients and phytonutrients. Using the American Heart Association’s diet quality scoring system which takes into account various aspects of a healthy diet (e.g., intake of fruits, vegetables, whole grains, lean proteins, etc.), 45.6% of US Adults consume a diet which is poor in quality [41,42]. As a solution to our low-quality diets, many researchers and practitioners suggest a healthy whole food based diet such as the Mediterranean diet or other plant-based, nutrient-dense diets [43,44,45]. This proves difficult in practice as it is estimated ~75% of the US population (ages ≥1 year) do not consume the recommended intake of fruit, and greater than 80% do not consume the recommended intake of vegetables [46]. Thus, while few would argue with a “foods first” approach to meeting nutritional needs, clearly other options are needed to practically improve human nutrition given the low prevalence of contemporary fruit, vegetable, and whole grain consumption. Furthermore, ultra-processed foods provide 58% of energy intake and 89% of added sugars in the American diet [47]. A recent meta-analysis revealed a significant relationship indicating that diets high in ultra-processed food intake had decreased levels of key nutrients for health (e.g., fiber, protein, potassium, zinc, and magnesium, and vitamins A, C, D, E, B12, and niacin) [48].
These poor dietary choices result in an inadequate intake of essential nutrients such as vitamins, minerals, and other micronutrients. Specifically, data from the National Health and Nutrition Examination Surveys (NHANES) indicate that large portions of the population had total usual intakes (including both food and dietary supplement use) below the estimated average requirement (EAR) for vitamin D (74%), vitamin E (67%), calcium (39%), magnesium (46%), and others [49]. Not only are we consuming unhealthier food as a population, but the food we are consuming is less nutritionally dense than in previous generations [50,51,52,53,54]. A review by Davis and colleagues indicated that the content of six essential nutrients (protein, calcium, phosphorus, iron, riboflavin, and ascorbic acid) in 43 garden crops (primarily vegetables) has declined between 5 and 40% since the 1950s, thus raising another challenge in meeting our Foundational Nutritional needs [50]. Furthermore, a review from Mayer and colleagues in 2022 found nutrient depletion in fruits and vegetables from 1941 to 2019 to be as high as 49 and 50% for iron and copper, respectively, in the UK [52]. In certain areas of the world, nutrient depletion may also be compounded by challenges to the climatic environment [15,55].
The reasons for these declines are multifactorial and regardless of the precise reason, nutrient-depleted diets lead to a range of health problems including diminished immune function, impaired cognitive development and function, anemia, osteoporosis, and even an increased risk of chronic diseases such as cardiovascular disease and certain cancers [56,57,58,59]. Obesity, as a specific example, is characterized by a chronic inflammatory state that is partially brought on by excessive malnourishment [60]. Physiological manifestations of the disease consist of cardiovascular pathologies (e.g., hypertension, atherosclerosis, etc.) and metabolic abnormalities (e.g., dyslipidemia, diabetes, etc.) [61]. Based on the physiological manifestations, it is clear how diet plays a crucial role in obesity. While there is a clear role of excessive caloric consumption that leads to the adipose tissue accumulation, the question of whether malnourishment is a component to obesity becomes compelling to answer. Kobylińska and colleagues outline obesity as a paradox; it can be defined by excessive energy consumption coupled by nutrient deficiencies [62]. This partially occurs because of the consumption of high-calorie foods with low nutrient content [63]. This results in a reported vitamin D deficiency in 80–90% of obese individuals [64,65], with other nutrient deficiencies such as biotin, thiamine, ascorbic acid, cobalamin, folic acid, chromium, selenium, and zinc among others [62,66,67,68,69]. While some argue whether these nutrient deficiencies exacerbate obesity or are a result of obesity, it is undeniable that nutrient deficiencies are occurring. This becomes even more important considering these deficiencies can contribute to the clinical manifestations and secondary disease states of obesity. It is clear that a new approach to attaining a health is needed as we face many challenges from a nutritional perspective.

4. History of Nutrient Recommendations and Further Needs

The recommended dietary allowances (RDAs) were first developed in the United States during World War II, stemming in response to the need for a standardized set of nutrient recommendations that could be used to guide public health policies and individual dietary choices [70,71,72]. The first set of RDAs was published in 1941 and included recommendations for nine essential nutrients: protein, calcium, phosphorus, iron, thiamin, riboflavin, vitamins A and D, niacin, and ascorbic acid (vitamin C) [73]. While formulated in the US, these recommendations were soon adopted in various capacities by other nations such as Canada and England and essentially served as the foundation for nutrition policies and recommendations worldwide [73,74]. Over the ensuing four decades, periodic updates to the RDA expanded recommendations to incorporate a wider range of nutrients, including vitamins, minerals, and macronutrients such as carbohydrates, fats, and protein [75]. However, at its inception, the RDA system was designed to provide guidelines for healthy individuals and to prevent nutrient deficiencies and malnutrition, rather than to prevent specific diseases or even optimize health. As such, criticisms arose regarding the limitations of the RDA system, particularly in relation to the lack of consideration given to individual variation in nutrient requirements, and the potential for overconsumption of nutrients at the upper end of the RDA range.
These critiques led to the introduction of the dietary reference intakes (DRIs) system in 1997 by the Institute of Medicine with the publication of a report establishing a new set of nutrient reference values replacing the RDAs, providing a more comprehensive and nuanced set of nutrient recommendations [25]. One of the key advantages of the DRI system is that it considers the varying nutrient needs of different population groups, including age, sex, and life stage in providing nutrient guidelines which were absent from the RDA system. The DRI system expanded in subsequent years with the publication of additional reports on other nutrients, including vitamin D, vitamin A, selenium, and others [25,76,77,78,79,80,81,82,83,84,85]. The DRI system provides four different types of nutrient reference values, including the RDA, adequate intake (AI), tolerable upper intake level (UL), and estimated average requirement (EAR) explained in more detail elsewhere [74].
While the RDA and DRI have been influential in promoting global nutritional health, they are not without limitations. The RDA is determined by defining an intake level that is a “risk for inadequacy” equating to 50% of the population (the EAR). Subsequently, variance is estimated with a generalized variation coefficient of 10%. Finally, two standard deviations at 20% are added to the EAR or the 97.5th percentile of requirements determined by the Monte Carlo simulation [86]. Currently, the RDA/EAR model does not have the capability to predict if a person is biologically deficient in a nutrient, rather, only if they are inadequate from the “notion of adequacy” [87]. As there are a plethora of factors that can impact the unique nutritional needs of an individual (e.g., age, sex, health conditions, genetic polymorphisms, socioeconomic factors, stress, geographic location, etc.), it is impossible to capture all the variables to have an accurate and quality input to yield a proficient statistical RDA model. Revisiting the RDA/EAR using biological data can provide a better model that utilizes biological relevance to determine inadequacy, instead of using mathematical relevance.
The intent of these guidelines has always been to prevent diseases of nutrient deficiency and never as a proactive approach to chronic degenerative disease prevention let alone optimization. In fact, there have been efforts to try to apply the dietary reference intakes to chronic disease prevention [88] with fluoride, dietary fiber, sodium, potassium, and calcium as the only nutrients with chronic disease endpoints [89]. Outside of these five nutrient disease claims, according to the expert panel, other nutrients do not have substantial evidence for the prevention of chronic disease [90]. As mentioned earlier in this review, chronic diseases such as diabetes, cancer, Alzheimer’s, and cardiovascular disease are largely preventable conditions that arise as a product of poor nutrition [2,3].
Periodically, the Food and Nutrition Board (FNB) reevaluates the DRIs and considers adding more nutrients to the DRIs acknowledging there may be other nutritional substances other than the main nutrients for which guidelines should be established [91]. However, the last revision to the DRIs was in 2011 to update recommendations for vitamin D and calcium while no other substantial changes have been made since the initial reports from 1997 to 2004 [25,77,78,79,80,84,85]. A sizable body of new research has emerged in the past decade, and the scientific literature largely suggests that new nutrients and dietary components should be considered as a part of the DRIs, as the evidence suggests these nutrients are necessary for human health [92,93,94]. Omega-3 fatty acids and bioactives such as phytonutrients have been specifically highlighted as nutrients which the DRIs excludes while they exert numerous health benefits and ability to reduce risk of various diseases [92,93,94,95,96]. The DRI system also does not account for nutrient bioavailability which can vary greatly depending on the nutrient and nutrient source (e.g., animal, vegetable, grain, supplement) consumed [25,26,28,97,98]. While the current DRI system accomplishes many basic goals, given the rise of chronic diseases attributable to inadequate dietary practices, it would be prudent for health professionals and policy makers to expand the list of nutrients which hold recommendations for daily consumption to provide a sound nutritional foundation for well-being and healthspan. In the next section, we propose a more inclusive perspective on nutrients which are essential to human health and longevity.

5. Nutrients and Foundational Nutrition

Essential nutrients are traditionally defined as an organic compound that serves a crucial physiological function in the human body and cannot be synthesized endogenously in humans (e.g., ascorbic acid); whereas non-essential nutrients may support a structure or function in the body but may be endogenously produced by other nutrient precursors in the body and are dependent on rate of conversion or metabolic processes internally. While these definitions provide a framework to understand the detrimental effects of nutrient underconsumption (e.g., malnutrition), it appears to fall short in establishing conditions for optimal nutrition over time to promote both healthspan and lifespan. For instance, the body of nutritional scientific literature provides numerous examples of non-vitamin or mineral nutrients which when consumed in sufficient amounts and in combination with other nutrients have profound effects on human health and longevity including various phytonutrients, omega-3 fatty acids, microbiome metabolites, and others. Moreover, the strength of the evidence is such that these and other functional nutrients (e.g., co-enzyme Q10, alpha-lipoic acid, etc.) should be included in our discussion of outlining the constituents of foundational nutrients (Table 1).
Phytonutrients are a broad array of naturally occurring compounds found in plants, including those found in adaptogens, functional mushrooms, and a variety of whole foods, which exert numerous beneficial biological effects when consumed through the diet [99]. Thousands of phytochemicals have been identified in plant matter, which have been generally categorized into several groups including phenolics (polyphenols), alkaloids, nitrogen-containing compounds, organosulfur compounds, phytosterols, and carotenoids [100]. The primary classes of polyphenols consist of phenolic acids, flavonoids, stilbenes, and ligands [101,102]. While there are extensive reviews of the positive effects of polyphenol consumption [103,104,105,106], in short, these bioactive compounds have been demonstrated to serve as intra- and extracellular antioxidants, stimulate microbial diversity, beneficially modulate the immune system, provide neuro-protective effects, and target multiple mechanistic pathways to enhance human health [107,108,109,110]. More specifically, polyphenol interventions have been shown to have immunomodulatory properties by decreasing pro-inflammatory cytokine production (e.g., IL-6, TNF-ɑ) in vitro and in human models [107,111,112,113]. Inflammatory cytokines play a crucial role in the immune response and can contribute to the development and progression of various diseases [114,115,116]. A meta-analysis including 30 RCTs and 5166 participants revealed significantly beneficial effects of polyphenol administration on decreasing illness intensity and the sum of symptom ratings in those experiencing viral acute respiratory tract infections [117]. A citrus bioflavonoid, hesperidin, has been shown to provide immune and cardiovascular benefits by increasing flow-mediated dilation, reducing blood pressure, and attenuating c-reactive protein (CRP) compared to a placebo [118,119,120]. Regarding obesity, polyphenols such as epigallocatechin gallate (EGCG) have been shown to positively influence reductions in adiposity likely by elevating energy expenditure and lipolysis [121,122,123]. Data also suggest polyphenols may be an effective means to suppress sensations of hunger and promote feelings of fullness and satiety which may contribute to observed reductions in fat mass [124].
Coenzyme Q10, also known as CoQ10, is a naturally occurring compound found in the mitochondria and serves an important role as an energy transfer molecule in the production of adenosine triphosphate (ATP) [125]. It also functions as a potent antioxidant, providing protection to cellular membranes from damage caused by free radicals. Given these antioxidant properties, it appears CoQ10 may provide a protective effect against cardiovascular disease by reducing the oxidative potential of low-density lipoprotein (LDL) particles which contribute to atherosclerosis [126,127]. Furthermore, a meta-analysis of 17 trials found that CoQ10 supplementation significantly reduced systolic blood pressure in patients with other metabolic diseases [128]. Moreover, animal models indicate that CoQ10 may help to improve brain health by improving cerebral blood flow, enhancing cognition, and attenuating impairments from neurological disorders. The antioxidant properties of CoQ10 may also support skin health by reducing the visible signs of aging and skin elasticity [129]. Regarding chronic inflammation, a meta-analysis found that short- and long-term CoQ10 administration taken in doses ranging from 60 to 500 mg/day significantly decreased production of inflammatory cytokines (e.g., C-reactive protein, tumor necrosis factor alpha, interleukin 6) which are commonly linked to various pathologies [130]. Overall, CoQ10 is a powerful nutrient that may offer numerous health benefits, particularly for heart health, energy production, and geroprotection.
Omega-3 fatty acids are a group of polyunsaturated fatty acids consisting of alpha-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) [131,132]. ALA is considered an essential fat since the body does not have the necessary enzymes for endogenous synthesis; however, recent data suggest that the US population generally consumes the recommended amount through their normal diet, commonly through seeds and nuts [133]. While a dietary reference intake has been established for ALA of 1.6 g and 1.1 g for men and women, respectively, the same cannot be said for EPA and DHA. Most health organizations suggest that humans consume approximately 250 to 500 mg of EPA and DHA combined. Given that ALA conversion into EPA and DHA is limited to approximately 15% [134], this would suggest that the average human would have to consume approximately two to three times the amount of ALA to meet the minimal EPA and DHA recommendations, not considering the vast amount of literature suggesting benefits of at least 1 g of EPA and DHA daily [135]. Consequently, the NIH recommends consuming EPA and DHA from whole food sources and/or dietary supplements to achieve adequate amounts in the diet [136]. Yet, a recent cross-sectional study indicated that 95% of US children and 68% of adults had serum omega-3 status below what is recommended by the Dietary Guidelines for America indicating underconsumption of omega-3 foods [137]. Omega-3 fatty acids have been shown to inhibit very low-density lipoprotein and triglyceride synthesis in the liver, decrease platelet-derived growth factor production and messenger RNA synthesis, and free radical production in neutrophils which contribute to improved endothelial health and attenuation of CVD [138,139,140]. Specifically, a large-scale clinical trial (n = 8179) found that consuming 4 g/day of a purified EPA omega-3 supplement for ~5 yrs significantly reduced the risk of experiencing ischemic events and cardiovascular death in individuals ≥ 45 yrs with CVD [141]. Further, a recent meta-analysis of 13 clinical trials administering between 0.376 and 4 g of omega-3 supplements per day indicated that omega-3 supplementation significantly reduced the risk of myocardial infarction, coronary heart disease (CHD), CHD related death, CVD related death, and total incidence of CVD in a dose-dependent manner [142]. Regarding cognition, another meta-analysis found that omega-3 administration significantly improved various domains of cognition (e.g., immediate recall, attention, processing speed) in adults with mild age-related cognitive impairment compared to a placebo [143]. Given the other reported benefits of omega-3 consumption on reductions in major adverse cardiovascular events [144], cancer development [145], Alzheimer’s and cognitive decline [146], depression [147], rheumatoid arthritis [148], and many other conditions [149], it is clear that these biological compounds are powerful agents in promoting human wellness across the lifespan and must be considered a part of one’s Foundational Nutrition.
While not traditionally defined as nutrients, substantial evidence has emerged over the past two decades indicating the profound health effects of probiotics and probiotic-containing foods for promoting gut microbiome community diversity [150]. Recent data suggest that these multifaceted bacteria and their metabolites (short chain fatty acids, tryptophan metabolites such as indole, aryl hydrocarbon receptor ligands, polyamines, etc.) have the potential to modulate the immune system, enhance nutrient availability, and influence other health domains (e.g., neurological, musculoskeletal, reproductive systems) [32,151]. Taken together, several prebiotic, probiotics, and their subsequent metabolites should be deemed “nutrabiotics” given their pleiotropic health benefits and the lost benefit on health and longevity in their absence [152]. Pre- and probiotics might also play a beneficial role in managing obesity. While obesity is not the only challenge to human health, it commonly manifests as a result of poor nutrition and is generally seen as a gateway to many other diseased states including type 2 diabetes, cardiovascular disease, non-alcoholic fatty liver disease, and hypertension [39,153,154,155]. Some evidence exists that prebiotics can promote feelings of satiety and promote weight control [156,157]. Moreover, the usage of prebiotics and probiotics has been shown to have success in clinical studies involving obese individuals [158,159,160,161]. A study by Niccolucci and colleagues in 2017 demonstrated that oligofructose-enriched inulin was able to reduce fat mass and body weight, alter fecal bile acid content, and alter the gut microbiome composition in overweight and obese children [160]. Specifically, these physiological outcomes appear to occur through modulation of Bifidobacterium spp., resulting in decreases in Bacteroides vulgatus [160]. While this is just one example, meta-analyses show that composition changes do occur that lead to meaningful physiological changes including changes in the inflammatory status of obese individuals. Beyond just obesity, it is generally understood that pre-/probiotics do contribute to an overall anti-inflammatory status as well as exert immunomodulatory effects [162,163]. The StatPearls page “Dietary Approaches To Obesity Treatment” has no mention of polyphenols, pre-/probiotics, or phospholipids and briefly mentions phytochemicals once with no follow-up or discussion [164]. Therefore, the purpose of Foundational Nutrition as a modern lens to view nutrition and nutritional science is to bring these dietary components to the foreground so they are discussed directly.
Mental health and high levels of stress are being reported at increasing rates globally [165,166,167]. While some nutrients within many current nutritional guidelines have been positively associated with mental health and stress, such as vitamin B9, B6, B12, and folate [4,8,168], other compounds that are not currently under nutritional guidelines that support mental health exist, such as phospholipids and specific bioactives found in botanicals. In vitro experimentation demonstrates that phospholipids can be neuroprotective and even regulate inflammatory processes through specific cell types like astrocytes [169]. With time, clinical studies are also emerging showing some clinical success between specific phospholipids and the treatment of mental disorders. Komori in 2015 saw that 100 mg of phosphatidylserine, 119 mg of docosahexaenoic acid, and 70 mg of eicosapentaenoic acid taken three times daily for 12 weeks was successful at managing depression in older individuals by regulating cortisol homeostasis [170]. Furthermore, bioactive phytonutrients found in Rhodiola rosea were shown to reduce symptoms of mild to moderate depression, mild anxiety, and provide a mood enhancing effect in a recent meta-analysis [171].
Although it is outside the scope of this article to review every pertinent nutrient to Foundational Nutrition, there are many other nutraceuticals which have garnered attention for the growing evidence regarding benefits to human health, longevity, and resiliency to stress. While not an exhaustive list, some compounds for nutrient consideration are: dietary nitrates, creatine, alpha-lipoic acid, adaptogens (e.g., Ashwagandha, Eleuthero, mushroom compounds), beta-alanine, quercetin, and citrulline [172,173,174,175,176,177,178,179,180]. Nevertheless, in re-examining the nutritional needs of an ever-changing population with unique health challenges, we propose that health professionals expand their definition of “essential nutrients” to help various populations attain the goal of comprehensive nutrition that aligns with the evolution of the scientific literature since the first RDA in 1941.

6. Importance of Gut Health

Nutrients, regardless of whether they come from diet or supplemental sources, go through various stages of digestion and absorption via the gastrointestinal system. It is a complex, multi-organ system with a nuanced communication system between human cells and microbial organisms. Loosely, the digestive system begins in the mouth and proceeds downward to the stomach and subsequently to the small and large intestines where the majority of the resident microorganisms aid in the digestive and metabolic processes. After the last stages of absorption, unabsorbed nutrients and waste are excreted from the body. During digestion, the amount of nutrient absorption can be modified due to biological processes in site-specific mechanisms.
The gastrointestinal tract is necessary for nutrient absorption, assimilation, and utilization, but it is not sufficient when assessing the necessities for Foundational Nutrition. Chiefly, the nutrient slurry that passes through the intestines encounters the gut microbiome which includes numerous microbial organisms across several domains of life. Bacteria, archaea, viruses, fungi, and other eukaryotic organisms play critical roles in shaping the microbial ecosystem. [181,182,183,184,185]. This rich, biodiverse microbiome which spans several domains of life leads to an array of metabolic processes that cannot occur due to limitations in the human genome. In many cases, this is crucial for human health as some microbial metabolic byproducts are key nutrients for humans. Half of a person’s necessary vitamin K comes directly from gut microbial metabolism [31] and specific intestinal epithelial transporters aid in the absorption of microbial derived nutrients [186] that would otherwise be excreted (e.g., various phytonutrients).
Several factors influence the gut microbiome’s composition, but nutrient availability, and conversely nutrient deficiency, are key factors [187]. Since nutrient availability shapes the microbial ecosystem, having a foundational and robust selection of nutrients is vital to maintain the array of metabolic processes that nourish the host. One study showed that malnourishment directly shifted microbial communities and resulted in sequential metabolic deficiencies which were detected in the host’s serum [188]. If nutrient deficiencies result in microbial-induced serum deficiencies, then it is possible that optimal nutritional states confer microbial-induced optimum serum concentrations. This, however, remains to be fully explored. While diet is generally understood to shift microbial composition, no study directly explores this phenomenon to date.
Beyond the gut microbiome, the cellular processes and organ systems can influence nutrient availability prior to nutrient delivery at the target site. Some nutrients can influence enzyme kinetics and even enzyme numbers. Optimal levels of a nutrient can change the substrate affinity of transport enzymes [189] or even upregulate enzyme expression [190]. As these cells work in concert in the organ system, optimal nutrition can amplify vital organ function. In the case of the liver, vitamins and minerals are critical in maintaining its histological integrity and catalytic function [191]. Damage to these organs can inhibit enzymatic activation of vital nutrients or result in lower nutrient stores [192]. Together, changes in enzyme number or kinetics and tissue integrity can influence nutrient availability at the target site. Experimental data show that these impairments, even at the gut level, can potentiate this effect systemically [193].
Microbiota disturbances are commonly noted in many disease states, but particularly in obesity. The obese gut microbiome is described as being low in taxonomic diversity [194,195] and in abnormal metabolic function [196,197]. Although, these findings are not always consistent from study to study [198], a recent meta-analysis by Pinart and colleagues examined 32 studies as well as other meta-analyses to describe the obese gut microbiome composition. Six of the studies indicated that there was a higher abundance of Firmicutes (F) with fewer abundances of Bacteroidetes (B), thus a characteristically high F:B ratio is commonly observed. At the genus level, there is a lower reported abundance of Bifidobacterium and Eggerthella in the obese gut microbiome; a higher abundance for Acidaminococcus, Anaerococcus, Catenibacterium, Dialister, Dorea, Escherichia-Shigella, Eubacterium, Fusobacterium, Megasphera, Prevotella, Roseburia, Streptococcus, and Sutterella were reported for the obese gut microbiome [199]. It is generally understood that these microbial disturbances in the gut microbiome contribute to the pathophysiology of obesity [147,200,201]. However, beyond just obesity and as previously mentioned, the gut microbiome plays a complex role in maintaining human physiology, homeostasis, and engages as a first responder to human diet and nutrition resulting in significant changes in nutrient absorption and human metabolism.
Digestion is a process with several potential bottlenecks. However, it could also serve as a mechanism to increase nutrient bioavailability. By increasing nutrient density in food and revisiting nutrient values that promote optimal biological processes beyond just homeostatic functions, the nutrient pool available to perform cellular work increases. These revisions could theoretically amplify the essential metabolic byproducts the gut microbiome provides to their host. Biochemically, optimal nutrition could increase nutrient affinity, leading to increased cellular and serum nutrient levels that can support organ function throughout the body. Synergistically, these work in concert to not only maintain human biology but promote vigor and vitality (Figure 2).

7. Merely the Beginning

Considering the health challenges facing our world population, the need is clear for continually improving recommendations and strategies to promote human health. The purpose of this review was to show that this global problem, and the clear lack of any immediate resolution, is indicative that the current lens with which the nutritional science community approaches optimal human nutrition is lacking. The concept of Foundational Nutrition prioritizes key pillars which have a profound impact on every health system in the human body. An emphasis on consuming highly bioavailable nutrients which exert synergistic effects elicits a greater impact on overall health than the sum of their individual or less-potent nutrient effects. Furthermore, consuming a diet rich in micronutrients and other phytonutrients not traditionally included in nutritional guidelines plays a key role in maintaining a healthy immune system, preventing chronic diseases, promoting optimal cognitive function, and countless other health benefits. Finally, in view of the myriad of health problems and diseased states which have been linked to poor gut health, Foundational Nutrition designates gut health as a focal point to improve systemic health and nutritional status. It is time to consider that the current nutrient crisis is not a problem of just a few nutrient deficiencies; rather, it is a concert of multiple factors leading to a global reduction in the human quality of life.
With this review, we hope to spark a new conversation around how society views human nutrition and how the scientific community approaches research on the topic. By opening up the space to have scientific discourse on how nutrients are viewed in the biological system, we can begin to elucidate the importance of a diverse diet in terms of nutrient composition. By reevaluating how society views nutrition, it is possible to pave the way to a solution of a problem that is only growing within the current frame of thinking. Only by accepting that modern food and the guidelines by which they are followed are not enough, can we, as a society, begin to tackle this global crisis.

Author Contributions

Conceptualization, J.R.T., T.O.K., T.M.M., and R.E.; writing—original draft preparation, J.R.T., T.O.K., T.M.M., and R.E.; writing—review and editing, J.R.T., T.O.K., T.M.M., D.D.C., A.R.J., and R.E.; All authors have read and agreed to the published version of the manuscript.

Funding

Article processing fees were funded by Athletic Greens Inc.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

No new data were created or analyzed in this study. Data sharing is not applicable to this article.

Conflicts of Interest

J.R.T., D.D.C., and A.R.J. have conducted sponsored research on nutritional supplements. D.D.C. has performed consulting related to nutritional supplements and food commodities. J.R.T., T.O.K., T.M.M., and R.E. are employees of Athletic Greens Inc. There are no other conflicts of interest to report.

References

  1. World Health Organization. Fact Sheet: Malnutrition; WHO: Geneva, Switzerland, 2021. [Google Scholar]
  2. Doll, R.; Peto, R. The Causes of Cancer: Quantitative Estimates of Avoidable Risks of Cancer in the United States Today. J. Natl. Cancer Inst. 1981, 66, 1191–1308. [Google Scholar] [CrossRef]
  3. Afshin, A.; Sur, P.J.; Fay, K.A.; Cornaby, L.; Ferrara, G.; Salama, J.S.; Mullany, E.C.; Abate, K.H.; Abbafati, C.; Abebe, Z.; et al. Health Effects of Dietary Risks in 195 Countries, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017. Lancet 2019, 393, 1958–1972. [Google Scholar] [CrossRef] [Green Version]
  4. Firth, J.; Gangwisch, J.E.; Borsini, A.; Wootton, R.E.; Mayer, E.A. Food and Mood: How Do Diet and Nutrition Affect Mental Wellbeing? BMJ 2020, 369, m2382. [Google Scholar] [CrossRef]
  5. Owen, L.; Corfe, B. The Role of Diet and Nutrition on Mental Health and Wellbeing. Proc. Nutr. Soc. 2017, 76, 425–426. [Google Scholar] [CrossRef] [Green Version]
  6. Agarwal, U.; Mishra, S.; Xu, J.; Levin, S.; Gonzales, J.; Barnard, N.D. A Multicenter Randomized Controlled Trial of a Nutrition Intervention Program in a Multiethnic Adult Population in the Corporate Setting Reduces Depression and Anxiety and Improves Quality of Life: The GEICO Study. Am. J. Health Promot. 2015, 29, 245–254. [Google Scholar] [CrossRef]
  7. Conner, T.S.; Brookie, K.L.; Richardson, A.C.; Polak, M.A. On Carrots and Curiosity: Eating Fruit and Vegetables Is Associated with Greater Flourishing in Daily Life. Br. J. Health Psychol. 2015, 20, 413–427. [Google Scholar] [CrossRef]
  8. Coppen, A.; Bailey, J. Enhancement of the Antidepressant Action of Fluoxetine by Folic Acid: A Randomised, Placebo Controlled Trial. J. Affect. Disord. 2000, 60, 121–130. [Google Scholar] [CrossRef]
  9. Mech, A.W.; Farah, A. Correlation of Clinical Response with Homocysteine Reduction during Therapy with Reduced B Vitamins in Patients with MDD Who Are Positive for MTHFR C677T or A1298C Polymorphism: A Randomized, Double-Blind, Placebo-Controlled Study. J. Clin. Psychiatry 2016, 77, 668–671. [Google Scholar] [CrossRef] [Green Version]
  10. Mozaffari-Khosravi, H.; Nabizade, L.; Yassini-Ardakani, S.M.; Hadinedoushan, H.; Barzegar, K. The Effect of 2 Different Single Injections of High Dose of Vitamin D on Improving the Depression in Depressed Patients with Vitamin D Deficiency: A Randomized Clinical Trial. J. Clin. Psychopharmacol. 2013, 33, 378. [Google Scholar] [CrossRef]
  11. Spasov, A.A.; Wikman, G.K.; Mandrikov, V.B.; Mironova, I.A.; Neumoin, V.V. A Double-Blind, Placebo-Controlled Pilot Study of the Stimulating and Adaptogenic Effect of Rhodiola Rosea SHR-5 Extract on the Fatigue of Students Caused by Stress during an Examination Period with a Repeated Low-Dose Regimen. Phytomedicine 2000, 7, 85–89. [Google Scholar] [CrossRef]
  12. James, W.P.; Nelson, M.; Ralph, A.; Leather, S. Socioeconomic Determinants of Health. The Contribution of Nutrition to Inequalities in Health. BMJ 1997, 314, 1545–1549. [Google Scholar] [CrossRef] [Green Version]
  13. Darmon, N.; Drewnowski, A. Contribution of Food Prices and Diet Cost to Socioeconomic Disparities in Diet Quality and Health: A Systematic Review and Analysis. Nutr. Rev. 2015, 73, 643–660. [Google Scholar] [CrossRef]
  14. Gundersen, C.; Ziliak, J.P. Food Insecurity And Health Outcomes. Health Aff. 2015, 34, 1830–1839. [Google Scholar] [CrossRef] [Green Version]
  15. Marti-Soler, H.; Guessous, I.; Gaspoz, J.-M.; Metcalf, P.; Deschamps, V.; Castetbon, K.; Malyutina, S.; Bobak, M.; Ruidavets, J.-B.; Bongard, V.; et al. Seasonality of Nutrient Intake—An Analysis Including over 44,000 Participants in 4 Countries. Clin. Nutr. ESPEN 2017, 21, 66–71. [Google Scholar] [CrossRef] [Green Version]
  16. Marshak, A.; Venkat, A.; Young, H.; Naumova, E.N. How Seasonality of Malnutrition Is Measured and Analyzed. Int. J. Environ. Res. Public Health 2021, 18, 1828. [Google Scholar] [CrossRef]
  17. Fardet, A.; Rock, E. Toward a New Philosophy of Preventive Nutrition: From a Reductionist to a Holistic Paradigm to Improve Nutritional Recommendations. Adv. Nutr. 2014, 5, 430–446. [Google Scholar] [CrossRef] [Green Version]
  18. Messina, M.; Lampe, J.W.; Birt, D.F.; Appel, L.J. Reductionism and the Narrowing Nutrition Perspective: Time for Reevaluation and Emphasis on Food Synergy. J. Acad. Nutr. Diet. 2001, 101, 1416. [Google Scholar]
  19. Yeum, K.-J.; Beretta, G.; Krinsky, N.I.; Russell, R.M.; Aldini, G. Synergistic Interactions of Antioxidant Nutrients in a Biological Model System. Nutrition 2009, 25, 839–846. [Google Scholar] [CrossRef]
  20. Christian, P.; West, K.P. Interactions between Zinc and Vitamin A: An Update. Am. J. Clin. Nutr. 1998, 68, 435S–441S. [Google Scholar] [CrossRef] [Green Version]
  21. Fardet, A.; Rock, E. The Search for a New Paradigm to Study Micronutrient and Phytochemical Bioavailability: From Reductionism to Holism. Med. Hypotheses 2014, 82, 181–186. [Google Scholar] [CrossRef]
  22. Yang, Q.; Liang, Q.; Balakrishnan, B.; Belobrajdic, D.P.; Feng, Q.-J.; Zhang, W. Role of Dietary Nutrients in the Modulation of Gut Microbiota: A Narrative Review. Nutrients 2020, 12, 381. [Google Scholar] [CrossRef] [Green Version]
  23. Zhan, Q.; Wang, R.; Thakur, K.; Feng, J.-Y.; Zhu, Y.-Y.; Zhang, J.-G.; Wei, Z.-J. Unveiling of Dietary and Gut-Microbiota Derived B Vitamins: Metabolism Patterns and Their Synergistic Functions in Gut-Brain Homeostasis. Crit. Rev. Food Sci. Nutr. 2022, 1–13. [Google Scholar] [CrossRef]
  24. Van Campen, D.R.; Glahn, R.P. Micronutrient Bioavailability Techniques: Accuracy, Problems and Limitations. Field Crops Res. 1999, 60, 93–113. [Google Scholar] [CrossRef]
  25. Institute of Medicine (US) Standing Committee on the Scientific Evaluationof Dietary Reference Intakes. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride; The National Academies Collection: Reports funded by National Institutes of Health; National Academies Press (US): Washington, DC, USA, 1997; ISBN 978-0-309-06350-0. [Google Scholar]
  26. Pardo, M.R.; Garicano Vilar, E.; San Mauro Martín, I.; Camina Martín, M.A. Bioavailability of Magnesium Food Supplements: A Systematic Review. Nutrition 2021, 89, 111294. [Google Scholar] [CrossRef] [PubMed]
  27. Mattar, G.; Haddarah, A.; Haddad, J.; Pujola, M.; Sepulcre, F. New Approaches, Bioavailability and the Use of Chelates as a Promising Method for Food Fortification. Food Chem. 2022, 373, 131394. [Google Scholar] [CrossRef]
  28. Melse-Boonstra, A. Bioavailability of Micronutrients from Nutrient-Dense Whole Foods: Zooming in on Dairy, Vegetables, and Fruits. Front. Nutr. 2020, 7, 101. [Google Scholar] [CrossRef] [PubMed]
  29. Rowland, I.; Gibson, G.; Heinken, A.; Scott, K.; Swann, J.; Thiele, I.; Tuohy, K. Gut Microbiota Functions: Metabolism of Nutrients and Other Food Components. Eur. J. Nutr. 2018, 57, 1–24. [Google Scholar] [CrossRef] [Green Version]
  30. Oh, R.; Brown, D.L. Vitamin B12 Deficiency. Am. Fam. Physician 2003, 67, 979–986. [Google Scholar] [PubMed]
  31. Hill, M.J. Intestinal Flora and Endogenous Vitamin Synthesis. Eur. J. Cancer Prev. 1997, 6 (Suppl. S1), S43–S45. [Google Scholar] [CrossRef] [PubMed]
  32. Judkins, T.C.; Archer, D.L.; Kramer, D.C.; Solch, R.J. Probiotics, Nutrition, and the Small Intestine. Curr. Gastroenterol. Rep. 2020, 22, 2. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Pérez-Torras, S.; Iglesias, I.; Llopis, M.; Lozano, J.J.; Antolín, M.; Guarner, F.; Pastor-Anglada, M. Transportome Profiling Identifies Profound Alterations in Crohn’s Disease Partially Restored by Commensal Bacteria. J. Crohn’s Colitis 2016, 10, 850–859. [Google Scholar] [CrossRef] [Green Version]
  34. Ford, A.C.; Spiegel, B.M.R.; Talley, N.J.; Moayyedi, P. Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis. Clin. Gastroenterol. Hepatol. 2009, 7, 1279–1286. [Google Scholar] [CrossRef]
  35. Dukowicz, A.C.; Lacy, B.E.; Levine, G.M. Small Intestinal Bacterial Overgrowth. Gastroenterol. Hepatol. 2007, 3, 112–122. [Google Scholar]
  36. Singh, R.; Zogg, H.; Wei, L.; Bartlett, A.; Ghoshal, U.C.; Rajender, S.; Ro, S. Gut Microbial Dysbiosis in the Pathogenesis of Gastrointestinal Dysmotility and Metabolic Disorders. J. Neurogastroenterol. Motil. 2021, 27, 19–34. [Google Scholar] [CrossRef] [PubMed]
  37. Wedlake, L.; A’Hern, R.; Russell, D.; Thomas, K.; Walters, J.R.F.; Andreyev, H.J.N. Systematic Review: The Prevalence of Idiopathic Bile Acid Malabsorption as Diagnosed by SeHCAT Scanning in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome. Aliment. Pharmacol. Ther. 2009, 30, 707–717. [Google Scholar] [CrossRef]
  38. Wei, Y.; Zhang, H.; Zhang, S.; Li, H. The Influence of Diet upon Liver Function Indices of Healthy Volunteers Resident in a Phase I Clinical Trail. Am. J. Transl. Res. 2019, 11, 3187–3194. [Google Scholar]
  39. World Health Organization. Obesity and Overweight Fact Sheet; WHO: Geneva, Switzerland, 2021. [Google Scholar]
  40. Heymsfield, S.B.; Wadden, T.A. Mechanisms, Pathophysiology, and Management of Obesity. N. Engl. J. Med. 2017, 376, 254–266. [Google Scholar] [CrossRef] [PubMed]
  41. Lloyd-Jones, D.M.; Hong, Y.; Labarthe, D.; Mozaffarian, D.; Appel, L.J.; Van Horn, L.; Greenlund, K.; Daniels, S.; Nichol, G.; Tomaselli, G.F. Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction: The American Heart Association’s Strategic Impact Goal through 2020 and beyond. Circulation 2010, 121, 586–613. [Google Scholar] [CrossRef] [Green Version]
  42. Rehm, C.D.; Peñalvo, J.L.; Afshin, A.; Mozaffarian, D. Dietary Intake among US Adults, 1999–2012. JAMA 2016, 315, 2542–2553. [Google Scholar] [CrossRef] [Green Version]
  43. Davis, C.; Bryan, J.; Hodgson, J.; Murphy, K. Definition of the Mediterranean Diet: A Literature Review. Nutrients 2015, 7, 9139–9153. [Google Scholar] [CrossRef] [Green Version]
  44. Knoops, K.T.; de Groot, L.C.; Kromhout, D.; Perrin, A.-E.; Moreiras-Varela, O.; Menotti, A.; Van Staveren, W.A. Mediterranean Diet, Lifestyle Factors, and 10-Year Mortality in Elderly European Men and Women: The HALE Project. JAMA 2004, 292, 1433–1439. [Google Scholar] [CrossRef] [PubMed]
  45. Tuso, P.J.; Ismail, M.H.; Ha, B.P.; Bartolotto, C. Nutritional Update for Physicians: Plant-Based Diets. Perm. J. 2013, 17, 61–66. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. U.S. Department of Health and Human Services; U.S. Department of Agriculture. 2015–2020 Dietary Guidelines for Americans, 8th ed.; December 2015. Available online: https://health.gov/our-work/food-nutrition/previous-dietary-guidelines/2015 (accessed on 3 March 2023).
  47. Steele, E.M.; Baraldi, L.G.; da Costa Louzada, M.L.; Moubarac, J.-C.; Mozaffarian, D.; Monteiro, C.A. Ultra-Processed Foods and Added Sugars in the US Diet: Evidence from a Nationally Representative Cross-Sectional Study. BMJ Open 2016, 6, e009892. [Google Scholar] [CrossRef] [Green Version]
  48. Martini, D.; Godos, J.; Bonaccio, M.; Vitaglione, P.; Grosso, G. Ultra-Processed Foods and Nutritional Dietary Profile: A Meta-Analysis of Nationally Representative Samples. Nutrients 2021, 13, 3390. [Google Scholar] [CrossRef] [PubMed]
  49. Wallace, T.C.; McBurney, M.; Fulgoni, V.L. Multivitamin/Mineral Supplement Contribution to Micronutrient Intakes in the United States, 2007–2010. J. Am. Coll. Nutr. 2014, 33, 94–102. [Google Scholar] [CrossRef]
  50. Davis, D.R.; Epp, M.D.; Riordan, H.D. Changes in USDA Food Composition Data for 43 Garden Crops, 1950 to 1999. J. Am. Coll. Nutr. 2004, 23, 669–682. [Google Scholar] [CrossRef]
  51. Mayer, A.-M. Historical Changes in the Mineral Content of Fruits and Vegetables. Br. Food J. 1997, 99, 207–211. [Google Scholar] [CrossRef]
  52. Mayer, A.-M.B.; Trenchard, L.; Rayns, F. Historical Changes in the Mineral Content of Fruit and Vegetables in the UK from 1940 to 2019: A Concern for Human Nutrition and Agriculture. Int. J. Food Sci. Nutr. 2022, 73, 315–326. [Google Scholar] [CrossRef] [PubMed]
  53. Thomas, D. A Study on the Mineral Depletion of the Foods Available to Us as a Nation over the Period 1940 to 1991. Nutr. Health 2003, 17, 85–115. [Google Scholar] [CrossRef]
  54. White, P.J.; Broadley, M.R. Historical Variation in the Mineral Composition of Edible Horticultural Products. J. Hortic. Sci. Biotechnol. 2005, 80, 660–667. [Google Scholar] [CrossRef]
  55. Tirado, M.C.; Crahay, P.; Mahy, L.; Zanev, C.; Neira, M.; Msangi, S.; Brown, R.; Scaramella, C.; Coitinho, D.C.; Müller, A. Climate Change and Nutrition: Creating a Climate for Nutrition Security. Food Nutr. Bull. 2013, 34, 533–547. [Google Scholar] [CrossRef]
  56. Black, M.M. Micronutrient Deficiencies and Cognitive Functioning. J. Nutr. 2003, 133, 3927S–3931S. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  57. Cascino, T.M.; Hummel, S.L. Nutrient Deficiencies in Heart Failure: A Micro Problem with Macro Effects? J. Am. Heart Assoc. 2018, 7, e010447. [Google Scholar] [CrossRef] [PubMed]
  58. Muñoz-Garach, A.; García-Fontana, B.; Muñoz-Torres, M. Nutrients and Dietary Patterns Related to Osteoporosis. Nutrients 2020, 12, 1986. [Google Scholar] [CrossRef] [PubMed]
  59. Reider, C.A.; Chung, R.-Y.; Devarshi, P.P.; Grant, R.W.; Hazels Mitmesser, S. Inadequacy of Immune Health Nutrients: Intakes in US Adults, the 2005–2016 NHANES. Nutrients 2020, 12, 1735. [Google Scholar] [CrossRef]
  60. Haidar, Y.M.; Cosman, B.C. Obesity Epidemiology. Clin. Colon. Rectal Surg. 2011, 24, 205–210. [Google Scholar] [CrossRef]
  61. Khanna, D.; Welch, B.S.; Rehman, A. Pathophysiology of Obesity. In StatPearls; StatPearls Publishing: Treasure Island, FL, USA, 2023. [Google Scholar]
  62. Kobylińska, M.; Antosik, K.; Decyk, A.; Kurowska, K. Malnutrition in Obesity: Is It Possible? Obes. Facts 2021, 15, 19–25. [Google Scholar] [CrossRef]
  63. Xanthakos, S.A. Nutritional Deficiencies in Obesity and After Bariatric Surgery. Pediatr. Clin. 2009, 56, 1105–1121. [Google Scholar] [CrossRef] [Green Version]
  64. Kaidar-Person, O.; Person, B.; Szomstein, S.; Rosenthal, R.J. Nutritional Deficiencies in Morbidly Obese Patients: A New Form of Malnutrition? Part A: Vitamins. Obes. Surg. 2008, 18, 870–876. [Google Scholar] [CrossRef]
  65. Strohmayer, E.; Via, M.A.; Yanagisawa, R. Metabolic Management Following Bariatric Surgery. Mt. Sinai J. Med. 2010, 77, 431–445. [Google Scholar] [CrossRef]
  66. Banach, W.; Nitschke, K.; Krajewska, N.; Mongiałło, W.; Matuszak, O.; Muszyński, J.; Skrypnik, D. The Association between Excess Body Mass and Disturbances in Somatic Mineral Levels. Int. J. Mol. Sci. 2020, 21, 7306. [Google Scholar] [CrossRef]
  67. Via, M. The Malnutrition of Obesity: Micronutrient Deficiencies That Promote Diabetes. ISRN Endocrinol. 2012, 2012, 103472. [Google Scholar] [CrossRef] [Green Version]
  68. García, O.P.; Ronquillo, D.; Caamaño, M.d.C.; Martínez, G.; Camacho, M.; López, V.; Rosado, J.L. Zinc, Iron and Vitamins A, C and E Are Associated with Obesity, Inflammation, Lipid Profile and Insulin Resistance in Mexican School-Aged Children. Nutrients 2013, 5, 5012–5030. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  69. Cigerli, O.; Parildar, H.; Dogruk Unal, A.; Tarcin, O.; Kut, A.; Eroglu, H.; Guvener, N. Vitamin deficiency and insulin resistance in nondiabetic obese patients. Acta Endocrinol. 2016, 12, 319–327. [Google Scholar] [CrossRef] [PubMed]
  70. National Research Council. Recommended Dietary Allowances; National Research Council-National Academy Press: Washington, DC, USA, 1989.
  71. Leitch, I. The Evolution of Dietary Standards. Nutr. Abstr. Rev. 1942, 11, 509–521. [Google Scholar]
  72. Roberts, L.J. Beginnings of the Recommended Dietary Allowances. J. Am. Diet. Assoc. 1958, 34, 903–908. [Google Scholar] [CrossRef] [PubMed]
  73. Davis, C.; Saltos, E. Over Time. Am. Eat. Habits Changes Conseq. 1999, 750, 33. [Google Scholar]
  74. Murphy, S.P.; Yates, A.A.; Atkinson, S.A.; Barr, S.I.; Dwyer, J. History of Nutrition: The Long Road Leading to the Dietary Reference Intakes for the United States and Canada. Adv. Nutr. 2016, 7, 157–168. [Google Scholar] [CrossRef] [Green Version]
  75. National Research Council. Diet and Health: Implications for Reducing Chronic Disease Risk; National Academies Press: Washington, DC, USA, 1989.
  76. Campbell, S. Dietary Reference Intakes: Water, Potassium, Sodium, Chloride, and Sulfate. Clin. Nutr. Insight 2004, 30, 1–4. [Google Scholar]
  77. Institute of Medicine (US) Food & Nutrition Board. Dietary Reference Intakes: A Risk Assessment Model for Establishing Upper Intake Levels for Nutrients; National Academies Press: Washington, DC, USA, 1998; ISBN 0-309-06348-5. [Google Scholar]
  78. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes F N B. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline; National Academies Press (US): Washington, DC, USA, 1998. [Google Scholar]
  79. Institute of Medicine (US). Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids: A Report. of the Panel on Dietary Antioxidants and Related Compounds, Subcommittees on Upper Reference Levels of Nutrients; National Academies Press: Washington, DC, USA, 2000; ISBN 0-309-06949-1. [Google Scholar]
  80. Institute of Medicine; Panel on Micronutrients; Nutrition Board; Subcommittees on Upper Reference Levels of Nutrients, of Interpretation; Use of Dietary Reference Intakes. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc; Dietary Reference Intakes; National Academies Press (US): Washington, DC, USA, 2002; ISBN 0-309-07290-5. [Google Scholar]
  81. Trumbo, P.; Schlicker, S.; Yates, A.A.; Poos, M. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein and Amino Acids.(Commentary). J. Am. Diet. Assoc. 2002, 102, 1621–1631. [Google Scholar] [CrossRef]
  82. Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Dietary Reference Intakes: Applications in Dietary Planning; National Academies Press (US): Washington, DC, USA, 2003. [Google Scholar]
  83. Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. DRI Dietary Reference Intakes: Applications in Dietary Assessment; National Academies Press (US): Washington, DC, USA, 2000. [Google Scholar]
  84. Institute of Medicine (US). Panel on Dietary Reference Intakes for Electrolytes, & Water. DRI, Dietary Reference Intakes for Water, Potassium, Sodium, Chloride, and Sulfate; National Academies Press (US): Washington, DC, USA, 2004; ISBN 0-309-09170-5. [Google Scholar]
  85. Del Valle, H.B.; Yaktine, A.L.; Taylor, C.L.; Ross, A.C. Dietary Reference Intakes for Calcium and Vitamin D; National Academies Press (US): Washington, DC, USA, 2011. [Google Scholar]
  86. Kohlmeier, M. Nutrient Metabolism: Structures, Functions, and Genes; Academic Press: Cambridge, MA, USA, 2015; ISBN 0-12-387788-1. [Google Scholar]
  87. De Lauzon, B.; Volatier, J.L.; Martin, A. A Monte Carlo Simulation to Validate the EAR Cut-Point Method for Assessing the Prevalence of Nutrient Inadequacy at the Population Level. Public Health Nutr. 2004, 7, 893–900. [Google Scholar] [CrossRef] [Green Version]
  88. National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Food and Nutrition Board; Committee on the Development of Guiding Principles for the Inclusion of Chronic Disease Endpoints in Future Dietary Reference Intakes. Guiding Principles for Developing Dietary Reference Intakes Based on Chronic Disease; Oria, M.P., Kumanyika, S., Eds.; National Academies Press (US): Washington, DC, USA, 3 August 2017. Available online: https://www.ncbi.nlm.nih.gov/books/NBK465016/ (accessed on 3 March 2023).
  89. Yaktine, A.L.; Ross, A.C. Milestones in DRI Development: What Does the Future Hold? Adv. Nutr. 2019, 10, 537–545. [Google Scholar] [CrossRef] [PubMed]
  90. Yetley, E.A.; MacFarlane, A.J.; Greene-Finestone, L.S.; Garza, C.; Ard, J.D.; Atkinson, S.A.; Bier, D.M.; Carriquiry, A.L.; Harlan, W.R.; Hattis, D. Options for Basing Dietary Reference Intakes (DRIs) on Chronic Disease Endpoints: Report from a Joint US-/Canadian-Sponsored Working Group. Am. J. Clin. Nutr. 2017, 105, 249S–285S. [Google Scholar] [CrossRef] [Green Version]
  91. MacFarlane, A.J.; Cogswell, M.E.; de Jesus, J.M.; Greene-Finestone, L.S.; Klurfeld, D.M.; Lynch, C.J.; Regan, K.; Yamini, S.; Group, J.C.-U.D.R.I.W. A Report of Activities Related to the Dietary Reference Intakes from the Joint Canada-US Dietary Reference Intakes Working Group. Am. J. Clin. Nutr. 2019, 109, 251–259. [Google Scholar] [CrossRef] [Green Version]
  92. Flock, M.R.; Harris, W.S.; Kris-Etherton, P.M. Long-Chain Omega-3 Fatty Acids: Time to Establish a Dietary Reference Intake. Nutr. Rev. 2013, 71, 692–707. [Google Scholar] [CrossRef]
  93. Racey, M.; MacFarlane, A.; Carlson, S.E.; Stark, K.D.; Plourde, M.; Field, C.J.; Yates, A.A.; Wells, G.; Grantham, A.; Bazinet, R.P. Dietary Reference Intakes Based on Chronic Disease Endpoints: Outcomes from a Case Study Workshop for Omega 3’s EPA and DHA. Appl. Physiol. Nutr. Metab. 2021, 46, 530–539. [Google Scholar] [CrossRef]
  94. Williamson, G.; Holst, B. Dietary Reference Intake (DRI) Value for Dietary Polyphenols: Are We Heading in the Right Direction? Br. J. Nutr. 2008, 99, S55–S58. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  95. Harris, W.S.; Mozaffarian, D.; Lefevre, M.; Toner, C.D.; Colombo, J.; Cunnane, S.C.; Holden, J.M.; Klurfeld, D.M.; Morris, M.C.; Whelan, J. Towards Establishing Dietary Reference Intakes for Eicosapentaenoic and Docosahexaenoic Acids. J. Nutr. 2009, 139, 804S–819S. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  96. Lupton, J.R.; Atkinson, S.A.; Chang, N.; Fraga, C.G.; Levy, J.; Messina, M.; Richardson, D.P.; van Ommen, B.; Yang, Y.; Griffiths, J.C.; et al. Exploring the Benefits and Challenges of Establishing a DRI-like Process for Bioactives. Eur. J. Nutr. 2014, 53, 1–9. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  97. Pressman, P.; Clemens, R.A.; Hayes, A.W. Bioavailability of Micronutrients Obtained from Supplements and Food: A Survey and Case Study of the Polyphenols. Toxicol. Res. Appl. 2017, 1, 2397847317696366. [Google Scholar] [CrossRef] [Green Version]
  98. Hambidge, K.M. Micronutrient Bioavailability: Dietary Reference Intakes and a Future Perspective. Am. J. Clin. Nutr. 2010, 91, 1430S–1432S. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  99. Gupta, C.; Prakash, D. Phytonutrients as Therapeutic Agents. J. Complement. Integr. Med. 2014, 11, 151–169. [Google Scholar] [CrossRef] [PubMed]
  100. Blekkenhorst, L.C.; Sim, M.; Bondonno, C.P.; Bondonno, N.P.; Ward, N.C.; Prince, R.L.; Devine, A.; Lewis, J.R.; Hodgson, J.M. Cardiovascular Health Benefits of Specific Vegetable Types: A Narrative Review. Nutrients 2018, 10, 595. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  101. Beecher, G.R. Phytonutrients’ Role in Metabolism: Effects on Resistance to Degenerative Processes. Nutr. Rev. 1999, 57, 3–6. [Google Scholar] [CrossRef]
  102. Carlsen, M.H.; Halvorsen, B.L.; Holte, K.; Bøhn, S.K.; Dragland, S.; Sampson, L.; Willey, C.; Senoo, H.; Umezono, Y.; Sanada, C.; et al. The Total Antioxidant Content of More than 3100 Foods, Beverages, Spices, Herbs and Supplements Used Worldwide. Nutr. J. 2010, 9, 3. [Google Scholar] [CrossRef]
  103. Cardona, F.; Andrés-Lacueva, C.; Tulipani, S.; Tinahones, F.J.; Queipo-Ortuño, M.I. Benefits of Polyphenols on Gut Microbiota and Implications in Human Health. J. Nutr. Biochem. 2013, 24, 1415–1422. [Google Scholar] [CrossRef] [Green Version]
  104. Fraga, C.G.; Galleano, M.; Verstraeten, S.V.; Oteiza, P.I. Basic Biochemical Mechanisms behind the Health Benefits of Polyphenols. Mol. Asp. Med. 2010, 31, 435–445. [Google Scholar] [CrossRef] [PubMed]
  105. Rana, A.; Samtiya, M.; Dhewa, T.; Mishra, V.; Aluko, R.E. Health Benefits of Polyphenols: A Concise Review. J. Food Biochem. 2022, 46, e14264. [Google Scholar] [CrossRef] [PubMed]
  106. Rasouli, H.; Farzaei, M.H.; Khodarahmi, R. Polyphenols and Their Benefits: A Review. Int. J. Food Prop. 2017, 20, 1700–1741. [Google Scholar] [CrossRef] [Green Version]
  107. Ding, S.; Jiang, H.; Fang, J. Regulation of Immune Function by Polyphenols. J. Immunol. Res. 2018, 2018, 1264074. [Google Scholar] [CrossRef] [Green Version]
  108. Kampa, M.; Nifli, A.-P.; Notas, G.; Castanas, E. Polyphenols and Cancer Cell Growth. Rev. Physiol. Biochem. Pharmacol. 2007, 159, 79–113. [Google Scholar] [CrossRef]
  109. Scalbert, A.; Johnson, I.T.; Saltmarsh, M. Polyphenols: Antioxidants and Beyond. Am. J. Clin. Nutr. 2005, 81, 215S–217S. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  110. Stevenson, D.E.; Hurst, R.D. Polyphenolic Phytochemicals—Just Antioxidants or Much More? Cell. Mol. Life Sci. 2007, 64, 2900–2916. [Google Scholar] [CrossRef] [PubMed]
  111. Siard, M.H.; McMurry, K.E.; Adams, A.A. Effects of Polyphenols Including Curcuminoids, Resveratrol, Quercetin, Pterostilbene, and Hydroxypterostilbene on Lymphocyte pro-Inflammatory Cytokine Production of Senior Horses in Vitro. Vet. Immunol. Immunopathol. 2016, 173, 50–59. [Google Scholar] [CrossRef]
  112. Yahfoufi, N.; Alsadi, N.; Jambi, M.; Matar, C. The Immunomodulatory and Anti-Inflammatory Role of Polyphenols. Nutrients 2018, 10, 1618. [Google Scholar] [CrossRef] [Green Version]
  113. Yao, W.; Zhang, X.; Xu, F.; Cao, C.; Liu, T.; Xue, Y. The Therapeutic Effects of Naringenin on Bronchial Pneumonia in Children. Pharmacol. Res. Perspect. 2021, 9, e00825. [Google Scholar] [CrossRef]
  114. Nieto-Vazquez, I.; Fernández-Veledo, S.; Krämer, D.K.; Vila-Bedmar, R.; Garcia-Guerra, L.; Lorenzo, M. Insulin Resistance Associated to Obesity: The Link TNF-Alpha. Arch. Physiol. Biochem. 2008, 114, 183–194. [Google Scholar] [CrossRef] [PubMed]
  115. Azizi, G.; Mirshafiey, A. The Potential Role of Proinflammatory and Antiinflammatory Cytokines in Alzheimer Disease Pathogenesis. Immunopharmacol. Immunotoxicol. 2012, 34, 881–895. [Google Scholar] [CrossRef] [PubMed]
  116. Soysal, P.; Arik, F.; Smith, L.; Jackson, S.E.; Isik, A.T. Inflammation, Frailty and Cardiovascular Disease. Adv. Exp. Med. Biol. 2020, 1216, 55–64. [Google Scholar] [CrossRef] [Green Version]
  117. Yao, J.; Zhang, Y.; Wang, X.-Z.; Zhao, J.; Yang, Z.-J.; Lin, Y.-P.; Sun, L.; Lu, Q.-Y.; Fan, G.-J. Flavonoids for Treating Viral Acute Respiratory Tract Infections: A Systematic Review and Meta-Analysis of 30 Randomized Controlled Trials. Front. Public Health 2022, 10, 814669. [Google Scholar] [CrossRef]
  118. Rizza, S.; Muniyappa, R.; Iantorno, M.; Kim, J.; Chen, H.; Pullikotil, P.; Senese, N.; Tesauro, M.; Lauro, D.; Cardillo, C. Citrus Polyphenol Hesperidin Stimulates Production of Nitric Oxide in Endothelial Cells While Improving Endothelial Function and Reducing Inflammatory Markers in Patients with Metabolic Syndrome. J. Clin. Endocrinol. Metab. 2011, 96, E782–E792. [Google Scholar] [CrossRef] [PubMed]
  119. Homayouni, F.; Haidari, F.; Hedayati, M.; Zakerkish, M.; Ahmadi, K. Blood Pressure Lowering and Anti-inflammatory Effects of Hesperidin in Type 2 Diabetes; a Randomized Double-blind Controlled Clinical Trial. Phytother. Res. 2018, 32, 1073–1079. [Google Scholar] [CrossRef] [PubMed]
  120. Morand, C.; Dubray, C.; Milenkovic, D.; Lioger, D.; Martin, J.F.; Scalbert, A.; Mazur, A. Hesperidin Contributes to the Vascular Protective Effects of Orange Juice: A Randomized Crossover Study in Healthy Volunteers. Am. J. Clin. Nutr. 2011, 93, 73–80. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  121. Bérubé-Parent, S.; Pelletier, C.; Doré, J.; Tremblay, A. Effects of Encapsulated Green Tea and Guarana Extracts Containing a Mixture of Epigallocatechin-3-Gallate and Caffeine on 24 h Energy Expenditure and Fat Oxidation in Men. Br. J. Nutr. 2005, 94, 432–436. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  122. Maki, K.C.; Reeves, M.S.; Farmer, M.; Yasunaga, K.; Matsuo, N.; Katsuragi, Y.; Komikado, M.; Tokimitsu, I.; Wilder, D.; Jones, F.; et al. Green Tea Catechin Consumption Enhances Exercise-Induced Abdominal Fat Loss in Overweight and Obese Adults. J. Nutr. 2009, 139, 264–270. [Google Scholar] [CrossRef] [Green Version]
  123. Vázquez Cisneros, L.C.; López-Uriarte, P.; López-Espinoza, A.; Navarro Meza, M.; Espinoza-Gallardo, A.C.; Guzmán Aburto, M.B. Effects of green tea and its epigallocatechin (EGCG) content on body weight and fat mass in humans: A systematic review. Nutr. Hosp. 2017, 34, 731–737. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  124. Stuby, J.; Gravestock, I.; Wolfram, E.; Pichierri, G.; Steurer, J.; Burgstaller, J.M. Appetite-Suppressing and Satiety-Increasing Bioactive Phytochemicals: A Systematic Review. Nutrients 2019, 11, 2238. [Google Scholar] [CrossRef] [Green Version]
  125. Bentinger, M.; Tekle, M.; Dallner, G. Coenzyme Q–Biosynthesis and Functions. Biochem. Biophys. Res. Commun. 2010, 396, 74–79. [Google Scholar] [CrossRef]
  126. Thomas, S.R.; Neuzil, J.; Stocker, R. Inhibition of LDL Oxidation by Ubiquinol-10. A Protective Mechanism for Coenzyme Q in Atherogenesis? Mol. Asp. Med. 1997, 18, 85–103. [Google Scholar] [CrossRef]
  127. Gao, L.; Mao, Q.; Cao, J.; Wang, Y.; Zhou, X.; Fan, L. Effects of Coenzyme Q10 on Vascular Endothelial Function in Humans: A Meta-Analysis of Randomized Controlled Trials. Atherosclerosis 2012, 221, 311–316. [Google Scholar] [CrossRef]
  128. Tabrizi, R.; Akbari, M.; Sharifi, N.; Lankarani, K.B.; Moosazadeh, M.; Kolahdooz, F.; Taghizadeh, M.; Asemi, Z. The Effects of Coenzyme Q10 Supplementation on Blood Pressures Among Patients with Metabolic Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. High Blood Press. Cardiovasc. Prev. 2018, 25, 41–50. [Google Scholar] [CrossRef] [PubMed]
  129. Žmitek, K.; Pogačnik, T.; Mervic, L.; Žmitek, J.; Pravst, I. The Effect of Dietary Intake of Coenzyme Q10 on Skin Parameters and Condition: Results of a Randomised, Placebo-Controlled, Double-Blind Study. BioFactors 2017, 43, 132–140. [Google Scholar] [CrossRef] [PubMed]
  130. Fan, L.; Feng, Y.; Chen, G.-C.; Qin, L.-Q.; Fu, C.; Chen, L.-H. Effects of Coenzyme Q10 Supplementation on Inflammatory Markers: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Pharmacol. Res. 2017, 119, 128–136. [Google Scholar] [CrossRef]
  131. Calder, P.C.; Yaqoob, P. Understanding Omega-3 Polyunsaturated Fatty Acids. Postgrad. Med. 2009, 121, 148–157. [Google Scholar] [CrossRef] [PubMed]
  132. Das, U.N. Essential Fatty Acids: Biochemistry, Physiology and Pathology. Biotechnol. J. Healthc. Nutr. Technol. 2006, 1, 420–439. [Google Scholar] [CrossRef]
  133. U.S. Department of Agriculture, Agricultural Research Service. What We Eat in America, 2011–2012; National Academies Press (US): Washington, DC, USA, 2015.
  134. Brenna, J.T.; Salem Jr, N.; Sinclair, A.J.; Cunnane, S.C. α-Linolenic Acid Supplementation and Conversion to n-3 Long-Chain Polyunsaturated Fatty Acids in Humans. Prostaglandins Leukot. Essent. Fat. Acids 2009, 80, 85–91. [Google Scholar] [CrossRef]
  135. Barry, A.R.; Dixon, D.L. Omega-3 Fatty Acids for the Prevention of Atherosclerotic Cardiovascular Disease. Pharmacotherapy 2021, 41, 1056–1065. [Google Scholar] [CrossRef]
  136. NIH Office of Dietary Supplements—Omega-3 Fatty Acids. Available online: https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/ (accessed on 3 March 2023).
  137. Murphy, R.A.; Devarshi, P.P.; Ekimura, S.; Marshall, K.; Mitmesser, S.H. Long-Chain Omega-3 Fatty Acid Serum Concentrations across Life Stages in the USA: An Analysis of NHANES 2011–2012. BMJ Open 2021, 11, e043301. [Google Scholar] [CrossRef]
  138. De Caterina, R.; Liao, J.K.; Libby, P. Fatty Acid Modulation of Endothelial Activation. Am. J. Clin. Nutr. 2000, 71, 213S–223S. [Google Scholar] [CrossRef] [Green Version]
  139. Goodfellow, J.; Bellamy, M.F.; Ramsey, M.W.; Jones, C.J.; Lewis, M.J. Dietary Supplementation with Marine Omega-3 Fatty Acids Improve Systemic Large Artery Endothelial Function in Subjects with Hypercholesterolemia. J. Am. Coll. Cardiol. 2000, 35, 265–270. [Google Scholar] [CrossRef] [Green Version]
  140. Jain, A.P.; Aggarwal, K.K.; Zhang, P.-Y. Omega-3 Fatty Acids and Cardiovascular Disease. Eur. Rev. Med. Pharmacol. Sci. 2015, 19, 441–445. [Google Scholar] [PubMed]
  141. Bhatt, D.L.; Steg, P.G.; Miller, M.; Brinton, E.A.; Jacobson, T.A.; Ketchum, S.B.; Doyle, R.T.; Juliano, R.A.; Jiao, L.; Granowitz, C.; et al. Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. N. Engl. J. Med. 2019, 380, 11–22. [Google Scholar] [CrossRef]
  142. Hu, Y.; Hu, F.B.; Manson, J.E. Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants. J. Am. Heart Assoc. 2019, 8, e013543. [Google Scholar] [CrossRef]
  143. Mazereeuw, G.; Lanctôt, K.L.; Chau, S.A.; Swardfager, W.; Herrmann, N. Effects of Omega-3 Fatty Acids on Cognitive Performance: A Meta-Analysis. Neurobiol. Aging 2012, 33, 1482.e17–1482.e29. [Google Scholar] [CrossRef] [PubMed]
  144. Abdelhamid, A.S.; Brown, T.J.; Brainard, J.S.; Biswas, P.; Thorpe, G.C.; Moore, H.J.; Deane, K.H.; Summerbell, C.D.; Worthington, H.V.; Song, F.; et al. Omega-3 Fatty Acids for the Primary and Secondary Prevention of Cardiovascular Disease. Cochrane Database Syst. Rev. 2020, 3, CD003177. [Google Scholar] [CrossRef] [PubMed]
  145. Manson, J.E.; Cook, N.R.; Lee, I.-M.; Christen, W.; Bassuk, S.S.; Mora, S.; Gibson, H.; Albert, C.M.; Gordon, D.; Copeland, T.; et al. Marine N-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer. N. Engl. J. Med. 2019, 380, 23–32. [Google Scholar] [CrossRef]
  146. van Gelder, B.M.; Tijhuis, M.; Kalmijn, S.; Kromhout, D. Fish Consumption, n-3 Fatty Acids, and Subsequent 5-y Cognitive Decline in Elderly Men: The Zutphen Elderly Study. Am. J. Clin. Nutr. 2007, 85, 1142–1147. [Google Scholar] [CrossRef] [Green Version]
  147. Li, F.; Liu, X.; Zhang, D. Fish Consumption and Risk of Depression: A Meta-Analysis. J. Epidemiol. Community Health 2016, 70, 299–304. [Google Scholar] [CrossRef] [Green Version]
  148. Sköldstam, L.; Börjesson, O.; Kjällman, A.; Seiving, B.; Akesson, B. Effect of Six Months of Fish Oil Supplementation in Stable Rheumatoid Arthritis. A Double-Blind, Controlled Study. Scand. J. Rheumatol. 1992, 21, 178–185. [Google Scholar] [CrossRef]
  149. Swanson, D.; Block, R.; Mousa, S.A. Omega-3 Fatty Acids EPA and DHA: Health Benefits throughout Life. Adv. Nutr. 2012, 3, 1–7. [Google Scholar] [CrossRef] [Green Version]
  150. Fernández-Alonso, M.; Aguirre Camorlinga, A.; Messiah, S.E.; Marroquin, E. Effect of Adding Probiotics to an Antibiotic Intervention on the Human Gut Microbial Diversity and Composition: A Systematic Review. J. Med. Microbiol. 2022, 71, 001625. [Google Scholar] [CrossRef]
  151. Sánchez, B.; Delgado, S.; Blanco-Míguez, A.; Lourenço, A.; Gueimonde, M.; Margolles, A. Probiotics, Gut Microbiota, and Their Influence on Host Health and Disease. Mol. Nutr. Food Res. 2017, 61, 1600240. [Google Scholar] [CrossRef] [Green Version]
  152. Chávarri, M.; Diez-Gutiérrez, L.; Marañón, I.; del Carmen Villarán, M.; Barrón, L.J.R. The Role of Probiotics in Nutritional Health: Probiotics as Nutribiotics. In Probiotics in the Prevention and Management of Human. Diseases; Elsevier: Amsterdam, The Netherlands, 2022; pp. 397–415. [Google Scholar]
  153. Czech, M.P. Insulin Action and Resistance in Obesity and Type 2 Diabetes. Nat. Med. 2017, 23, 804–814. [Google Scholar] [CrossRef] [PubMed]
  154. Ortega, F.B.; Lavie, C.J.; Blair, S.N. Obesity and Cardiovascular Disease. Circ. Res. 2016, 118, 1752–1770. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  155. Polyzos, S.A.; Kountouras, J.; Mantzoros, C.S. Obesity and Nonalcoholic Fatty Liver Disease: From Pathophysiology to Therapeutics. Metabolism 2019, 92, 82–97. [Google Scholar] [CrossRef] [PubMed]
  156. Parnell, J.A.; Raman, M.; Rioux, K.P.; Reimer, R.A. The Potential Role of Prebiotic Fibre for Treatment and Management of Non-Alcoholic Fatty Liver Disease and Associated Obesity and Insulin Resistance. Liver Int. 2012, 32, 701–711. [Google Scholar] [CrossRef]
  157. Cerdó, T.; García-Santos, J.A.; Bermúdez, M.G.; Campoy, C. The Role of Probiotics and Prebiotics in the Prevention and Treatment of Obesity. Nutrients 2019, 11, 635. [Google Scholar] [CrossRef] [Green Version]
  158. Ben Othman, R.; Ben Amor, N.; Mahjoub, F.; Berriche, O.; El Ghali, C.; Gamoudi, A.; Jamoussi, H. A Clinical Trial about Effects of Prebiotic and Probiotic Supplementation on Weight Loss, Psychological Profile and Metabolic Parameters in Obese Subjects. Endocrinol. Diabetes Metab. 2023, 6, e402. [Google Scholar] [CrossRef]
  159. Wiciński, M.; Gębalski, J.; Gołębiewski, J.; Malinowski, B. Probiotics for the Treatment of Overweight and Obesity in Humans—A Review of Clinical Trials. Microorganisms 2020, 8, 1148. [Google Scholar] [CrossRef]
  160. Nicolucci, A.C.; Hume, M.P.; Martínez, I.; Mayengbam, S.; Walter, J.; Reimer, R.A. Prebiotics Reduce Body Fat and Alter Intestinal Microbiota in Children Who Are Overweight or With Obesity. Gastroenterology 2017, 153, 711–722. [Google Scholar] [CrossRef] [Green Version]
  161. She, J.; Wong, C.C.; Yu, J. Targeted Prebiotics Alter the Obese Gut Microbiome in Humans. Signal. Transduct. Target. Ther. 2021, 6, 363. [Google Scholar] [CrossRef] [PubMed]
  162. Bilal, M.; Ashraf, S.; Zhao, X. Dietary Component-Induced Inflammation and Its Amelioration by Prebiotics, Probiotics, and Synbiotics. Front. Nutr. 2022, 9, 931458. [Google Scholar] [CrossRef] [PubMed]
  163. Cristofori, F.; Dargenio, V.N.; Dargenio, C.; Miniello, V.L.; Barone, M.; Francavilla, R. Anti-Inflammatory and Immunomodulatory Effects of Probiotics in Gut Inflammation: A Door to the Body. Front. Immunol. 2021, 12, 578386. [Google Scholar] [CrossRef] [PubMed]
  164. Parmar, R.M.; Can, A.S. Dietary Approaches To Obesity Treatment. In StatPearls; StatPearls Publishing: Treasure Island, FL, USA, 2023. [Google Scholar]
  165. Keyes, K.M.; Gary, D.; O’Malley, P.M.; Hamilton, A.; Schulenberg, J. Recent Increases in Depressive Symptoms among US Adolescents: Trends from 1991 to 2018. Soc. Psychiatry Psychiatr. Epidemiol. 2019, 54, 987–996. [Google Scholar] [CrossRef]
  166. Lim, G.Y.; Tam, W.W.; Lu, Y.; Ho, C.S.; Zhang, M.W.; Ho, R.C. Prevalence of Depression in the Community from 30 Countries between 1994 and 2014. Sci. Rep. 2018, 8, 2861. [Google Scholar] [CrossRef] [Green Version]
  167. Lipson, S.K.; Lattie, E.G.; Eisenberg, D. Increased Rates of Mental Health Service Utilization by U.S. College Students: 10-Year Population-Level Trends (2007–2017). Psychiatr. Serv. 2019, 70, 60–63. [Google Scholar] [CrossRef]
  168. Durrani, D.; Idrees, R.; Idrees, H.; Ellahi, A. Vitamin B6: A New Approach to Lowering Anxiety, and Depression? Ann. Med. Surg. 2022, 82, 104663. [Google Scholar] [CrossRef]
  169. Donoso, F.; Schverer, M.; Rea, K.; Pusceddu, M.M.; Roy, B.L.; Dinan, T.G.; Cryan, J.F.; Schellekens, H. Neurobiological Effects of Phospholipids in Vitro: Relevance to Stress-Related Disorders. Neurobiol. Stress 2020, 13, 100252. [Google Scholar] [CrossRef]
  170. Komori, T. The Effects of Phosphatidylserine and Omega-3 Fatty Acid-Containing Supplement on Late Life Depression. Ment. Illn. 2015, 7, 5647. [Google Scholar] [CrossRef]
  171. Konstantinos, F.; Heun, R. The Effects of Rhodiola Rosea Supplementation on Depression, Anxiety and Mood–A Systematic Review. Glob. Psychiatry 2020, 3, 72–82. [Google Scholar] [CrossRef] [Green Version]
  172. Trexler, E.T.; Smith-Ryan, A.E.; Stout, J.R.; Hoffman, J.R.; Wilborn, C.D.; Sale, C.; Kreider, R.B.; Jäger, R.; Earnest, C.P.; Bannock, L. International Society of Sports Nutrition Position Stand: Beta-Alanine. J. Int. Soc. Sport. Nutr. 2015, 12, 30. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  173. Barkhidarian, B.; Khorshidi, M.; Shab-Bidar, S.; Hashemi, B. Effects of L-Citrulline Supplementation on Blood Pressure: A Systematic Review and Meta-Analysis. Avicenna J. Phytomed. 2019, 9, 10. [Google Scholar]
  174. Mousavi, S.M.; Shab-Bidar, S.; Kord-Varkaneh, H.; Khorshidi, M.; Djafarian, K. Effect of Alpha-Lipoic Acid Supplementation on Lipid Profile: A Systematic Review and Meta-Analysis of Controlled Clinical Trials. Nutrition 2019, 59, 121–130. [Google Scholar] [CrossRef] [PubMed]
  175. Jackson, J.K.; Patterson, A.J.; MacDonald-Wicks, L.K.; Oldmeadow, C.; McEvoy, M.A. The Role of Inorganic Nitrate and Nitrite in Cardiovascular Disease Risk Factors: A Systematic Review and Meta-Analysis of Human Evidence. Nutr. Rev. 2018, 76, 348–371. [Google Scholar] [CrossRef]
  176. Anghelescu, I.-G.; Edwards, D.; Seifritz, E.; Kasper, S. Stress Management and the Role of Rhodiola Rosea: A Review. Int. J. Psychiatry Clin. Pract. 2018, 22, 242–252. [Google Scholar] [CrossRef] [Green Version]
  177. Cheah, K.L.; Norhayati, M.N.; Husniati Yaacob, L.; Abdul Rahman, R. Effect of Ashwagandha (Withania Somnifera) Extract on Sleep: A Systematic Review and Meta-Analysis. PLoS ONE 2021, 16, e0257843. [Google Scholar] [CrossRef]
  178. Serban, M.-C.; Sahebkar, A.; Zanchetti, A.; Mikhailidis, D.P.; Howard, G.; Antal, D.; Andrica, F.; Ahmed, A.; Aronow, W.S.; Muntner, P. Effects of Quercetin on Blood Pressure: A Systematic Review and Meta-analysis of Randomized Controlled Trials. J. Am. Heart Assoc. 2016, 5, e002713. [Google Scholar] [CrossRef] [Green Version]
  179. Hernandez-Garcia, D.; Granado-Serrano, A.B.; Martín-Gari, M.; Naudi, A.; Serrano, J.C. Efficacy of Panax Ginseng Supplementation on Blood Lipid Profile. A Meta-Analysis and Systematic Review of Clinical Randomized Trials. J. Ethnopharmacol. 2019, 243, 112090. [Google Scholar] [CrossRef]
  180. Kreider, R.B.; Stout, J.R. Creatine in Health and Disease. Nutrients 2021, 13, 447. [Google Scholar] [CrossRef]
  181. Belvoncikova, P.; Splichalova, P.; Videnska, P.; Gardlik, R. The Human Mycobiome: Colonization, Composition and the Role in Health and Disease. J. Fungi 2022, 8, 1046. [Google Scholar] [CrossRef]
  182. Cao, Z.; Sugimura, N.; Burgermeister, E.; Ebert, M.P.; Zuo, T.; Lan, P. The Gut Virome: A New Microbiome Component in Health and Disease. eBioMedicine 2022, 81, 104113. [Google Scholar] [CrossRef] [PubMed]
  183. Chibani, C.M.; Mahnert, A.; Borrel, G.; Almeida, A.; Werner, A.; Brugère, J.-F.; Gribaldo, S.; Finn, R.D.; Schmitz, R.A.; Moissl-Eichinger, C. A Catalogue of 1,167 Genomes from the Human Gut Archaeome. Nat. Microbiol. 2022, 7, 48–61. [Google Scholar] [CrossRef]
  184. Ghosh, T.S.; Shanahan, F.; O’Toole, P.W. The Gut Microbiome as a Modulator of Healthy Ageing. Nat. Rev. Gastroenterol. Hepatol. 2022, 19, 565–584. [Google Scholar] [CrossRef]
  185. Laforest-Lapointe, I.; Arrieta, M.-C. Microbial Eukaryotes: A Missing Link in Gut Microbiome Studies. mSystems 2018, 3, e00201-17. [Google Scholar] [CrossRef] [Green Version]
  186. Said, H.M.; Mohammed, Z.M. Intestinal Absorption of Water-Soluble Vitamins: An Update. Curr. Opin. Gastroenterol. 2006, 22, 140–146. [Google Scholar] [CrossRef]
  187. Leeming, E.R.; Johnson, A.J.; Spector, T.D.; Le Roy, C.I. Effect of Diet on the Gut Microbiota: Rethinking Intervention Duration. Nutrients 2019, 11, 2862. [Google Scholar] [CrossRef] [Green Version]
  188. Kumar, M.; Ji, B.; Babaei, P.; Das, P.; Lappa, D.; Ramakrishnan, G.; Fox, T.E.; Haque, R.; Petri, W.A.; Bäckhed, F.; et al. Gut Microbiota Dysbiosis Is Associated with Malnutrition and Reduced Plasma Amino Acid Levels: Lessons from Genome-Scale Metabolic Modeling. Metab. Eng. 2018, 49, 128–142. [Google Scholar] [CrossRef] [Green Version]
  189. Böhmer, C.; Bröer, A.; Munzinger, M.; Kowalczuk, S.; Rasko, J.E.J.; Lang, F.; Bröer, S. Characterization of Mouse Amino Acid Transporter B0AT1 (Slc6a19). Biochem. J. 2005, 389, 745–751. [Google Scholar] [CrossRef] [Green Version]
  190. Ferraris, R.P. Nutrient Transport, Regulation Of. In Encyclopedia of Gastroenterology; Johnson, L.R., Ed.; Elsevier: New York, NY, USA, 2004; pp. 754–759. ISBN 978-0-12-386860-2. [Google Scholar]
  191. Licata, A.; Zerbo, M.; Como, S.; Cammilleri, M.; Soresi, M.; Montalto, G.; Giannitrapani, L. The Role of Vitamin Deficiency in Liver Disease: To Supplement or Not Supplement? Nutrients 2021, 13, 4014. [Google Scholar] [CrossRef]
  192. Bjelakovic, G.; Nikolova, D.; Bjelakovic, M.; Gluud, C. Vitamin D Supplementation for Chronic Liver Diseases in Adults. Cochrane Database Syst. Rev. 2017, 2017, CD011564. [Google Scholar] [CrossRef]
  193. Abdul-Muneer, P.M.; Alikunju, S.; Schuetz, H.; Szlachetka, A.M.; Ma, X.; Haorah, J. Impairment of Thiamine Transport at the GUT-BBB-AXIS Contributes to Wernicke’s Encephalopathy. Mol. Neurobiol. 2018, 55, 5937–5950. [Google Scholar] [CrossRef]
  194. Breton, J.; Galmiche, M.; Déchelotte, P. Dysbiotic Gut Bacteria in Obesity: An Overview of the Metabolic Mechanisms and Therapeutic Perspectives of Next-Generation Probiotics. Microorganisms 2022, 10, 452. [Google Scholar] [CrossRef]
  195. Kim, M.-H.; Yun, K.E.; Kim, J.; Park, E.; Chang, Y.; Ryu, S.; Kim, H.-L.; Kim, H.-N. Gut Microbiota and Metabolic Health among Overweight and Obese Individuals. Sci. Rep. 2020, 10, 19417. [Google Scholar] [CrossRef]
  196. Sanmiguel, C.; Gupta, A.; Mayer, E.A. Gut Microbiome and Obesity: A Plausible Explanation for Obesity. Curr. Obes. Rep. 2015, 4, 250–261. [Google Scholar] [CrossRef] [Green Version]
  197. Chen, X.; Sun, H.; Jiang, F.; Shen, Y.; Li, X.; Hu, X.; Shen, X.; Wei, P. Alteration of the Gut Microbiota Associated with Childhood Obesity by 16S RRNA Gene Sequencing. PeerJ 2020, 8, e8317. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  198. Castaner, O.; Goday, A.; Park, Y.-M.; Lee, S.-H.; Magkos, F.; Shiow, S.-A.T.E.; Schröder, H. The Gut Microbiome Profile in Obesity: A Systematic Review. Int. J. Endocrinol. 2018, 2018, 4095789. [Google Scholar] [CrossRef]
  199. Pinart, M.; Dötsch, A.; Schlicht, K.; Laudes, M.; Bouwman, J.; Forslund, S.K.; Pischon, T.; Nimptsch, K. Gut Microbiome Composition in Obese and Non-Obese Persons: A Systematic Review and Meta-Analysis. Nutrients 2021, 14, 12. [Google Scholar] [CrossRef]
  200. Davis, C.D. The Gut Microbiome and Its Role in Obesity. Nutr. Today 2016, 51, 167–174. [Google Scholar] [CrossRef] [Green Version]
  201. Aoun, A.; Darwish, F.; Hamod, N. The Influence of the Gut Microbiome on Obesity in Adults and the Role of Probiotics, Prebiotics, and Synbiotics for Weight Loss. Prev. Nutr. Food Sci. 2020, 25, 113–123. [Google Scholar] [CrossRef]
Figure 1. Schematic representation of Foundational Nutrition. Three tenets or pillars of Foundational Nutrition are whole food consumption, micronutrients and other functional nutrients (e.g., phytonutrients), and gut health as key to overall human health. Synergy and bioavailability are themes that connect these three tenets. Specifically, synergy in how nutrients work together, synergy in how these nutrients improve gut health and the function of the digestive system to subsequently deliver nutrients systemically, and how nature provides whole foods (e.g., fruits, vegetables, nuts, etc.) which contain a complex matrix of nutrients that work together synergistically as opposed to being consumed in isolation. Bioavailability also links these pillars in the way bioavailable forms of nutrients are found in whole sources, bioavailable forms of supplemental micronutrients are superior to improving health, and optimal gut health by proxy can increase the bioavailability of nutrient through the microbiome and health of organs in the digestive system.
Figure 1. Schematic representation of Foundational Nutrition. Three tenets or pillars of Foundational Nutrition are whole food consumption, micronutrients and other functional nutrients (e.g., phytonutrients), and gut health as key to overall human health. Synergy and bioavailability are themes that connect these three tenets. Specifically, synergy in how nutrients work together, synergy in how these nutrients improve gut health and the function of the digestive system to subsequently deliver nutrients systemically, and how nature provides whole foods (e.g., fruits, vegetables, nuts, etc.) which contain a complex matrix of nutrients that work together synergistically as opposed to being consumed in isolation. Bioavailability also links these pillars in the way bioavailable forms of nutrients are found in whole sources, bioavailable forms of supplemental micronutrients are superior to improving health, and optimal gut health by proxy can increase the bioavailability of nutrient through the microbiome and health of organs in the digestive system.
Nutrients 15 02837 g001
Figure 2. Foundational Nutrition implications on gut microbiome health. Human diet is one of the most important variables that dictates the community composition of the gut microbiome. Suboptimal diets that are generally lacking in robust nutrients sources and are highly processed reduces the nutritional inputs the gut microbiome receives. Consequently, the gut microbiome will shift towards a metabolically simplistic composition and reduce global diversity. Reductions in community composition can lead to reductions in metabolic diversity, which has been shown to reduce the amount of some nutrients in human serum which can lead to systemic abnormalities and even become precursors to disease states. Conversely, supporting the gut microbiome with a diverse input of nutrients supports a wide array of microbiota, including rare taxa whose metabolism is critical in maintaining human homeostasis. A diverse microbiome community composition leads to a diverse metabolite composition which is bioavailable for the host to utilize. This keeps the body’s physiology functional and promotes global well-being.
Figure 2. Foundational Nutrition implications on gut microbiome health. Human diet is one of the most important variables that dictates the community composition of the gut microbiome. Suboptimal diets that are generally lacking in robust nutrients sources and are highly processed reduces the nutritional inputs the gut microbiome receives. Consequently, the gut microbiome will shift towards a metabolically simplistic composition and reduce global diversity. Reductions in community composition can lead to reductions in metabolic diversity, which has been shown to reduce the amount of some nutrients in human serum which can lead to systemic abnormalities and even become precursors to disease states. Conversely, supporting the gut microbiome with a diverse input of nutrients supports a wide array of microbiota, including rare taxa whose metabolism is critical in maintaining human homeostasis. A diverse microbiome community composition leads to a diverse metabolite composition which is bioavailable for the host to utilize. This keeps the body’s physiology functional and promotes global well-being.
Nutrients 15 02837 g002
Table 1. Comparison of nutrients included in the recommended daily allowances (RDAs) and dietary reference intakes (DRIs) vs. those proposed for consideration in the framework of Foundational Nutrition.
Table 1. Comparison of nutrients included in the recommended daily allowances (RDAs) and dietary reference intakes (DRIs) vs. those proposed for consideration in the framework of Foundational Nutrition.
Nutrients in Current RDA and DRINutrients for Foundational Nutrition
Macromolecules
  • Lipids (Total fat, Cholesterol, etc.)
  • Carbohydrates (Total sugars, Fiber, etc.)
  • Proteins
  • Lipids (Total fat, Cholesterol, etc.)
  • Carbohydrates (Total sugars, Fiber, etc.)
  • Proteins
Vitamins and Minerals
  • Vitamin E
  • Vitamin C
  • Vitamin B12
  • etc.
  • Zinc
  • Sodium
  • Copper
  • Iron
  • etc.
  • Vitamin E
  • Vitamin C
  • Vitamin B12
  • etc.
  • Zinc
  • Sodium
  • Copper
  • Iron
  • etc.
Phytonutrients
  • Phenolic acids
  • Flavonoids
  • Lignans
  • Stilbenes
Prebiotics and Probiotics
  • Fermentable fibers (fructans, beta-glucans, pectins, etc.)
  • Lactic acid Bacteria (Lactobacillus spp.,
  • Lactococcus spp., Bifidobacterium spp, etc.)
Functional Nutrients
  • Coenzyme Q10
  • Alpha Lipoic Acid
  • Phospholipids
  • etc.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Townsend, J.R.; Kirby, T.O.; Marshall, T.M.; Church, D.D.; Jajtner, A.R.; Esposito, R. Foundational Nutrition: Implications for Human Health. Nutrients 2023, 15, 2837. https://doi.org/10.3390/nu15132837

AMA Style

Townsend JR, Kirby TO, Marshall TM, Church DD, Jajtner AR, Esposito R. Foundational Nutrition: Implications for Human Health. Nutrients. 2023; 15(13):2837. https://doi.org/10.3390/nu15132837

Chicago/Turabian Style

Townsend, Jeremy R., Trevor O. Kirby, Tess M. Marshall, David D. Church, Adam R. Jajtner, and Ralph Esposito. 2023. "Foundational Nutrition: Implications for Human Health" Nutrients 15, no. 13: 2837. https://doi.org/10.3390/nu15132837

APA Style

Townsend, J. R., Kirby, T. O., Marshall, T. M., Church, D. D., Jajtner, A. R., & Esposito, R. (2023). Foundational Nutrition: Implications for Human Health. Nutrients, 15(13), 2837. https://doi.org/10.3390/nu15132837

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop